Gene symbol | mRNA description | FCa | P-value |
---|---|---|---|
TOP2A | topoisomerase (DNA) II alpha 170Â kDa | 2.91 | 0.013 |
CDKN3 | cyclin-dependent kinase inhibitor 3 | 2.64 | 0.010 |
ARHGAP11A | Rho GTPase activating protein 11A | 2.61 | 0.029 |
STMN1 | stathmin 1 | 2.57 | 0.015 |
ECT2 | epithelial cell transforming sequence 2 oncogene | 2.53 | 0.023 |
DEPDC1 | DEP domain containing 1 | 2.51 | 0.015 |
CENPA | centromere protein A | 2.49 | 0.006 |
CENPF | centromere protein F, 350/400Â kDa (mitosin) | 2.45 | 0.017 |
CKAP2 | cytoskeleton associated protein 2 | 2.39 | 0.024 |
PRR11 | proline rich 11 | 2.32 | 0.036 |
KIF11 | kinesin family member 11 | 2.25 | 0.007 |
KIF20A | kinesin family member 20A | 2.21 | 0.017 |
BUB1B | budding uninhibited by benzimidazoles 1 homolog beta | 2.20 | 0.004 |
LOC618147 | histone cluster 1, H2ai-like | 2.17 | 0.002 |
KIF4A | kinesin family member 4A | 2.13 | 0.018 |
LOC787465 | histone H2B type 1-like | 2.10 | 0.006 |
GAS2L3 | growth arrest-specific 2 like 3 | 1.99 | 0.018 |
SMC4 | structural maintenance of chromosomes 4 | 1.98 | 0.011 |
SMC2 | structural maintenance of chromosomes 2 | 1.96 | 0.011 |
RRM2 | ribonucleotide reductase M2 | 1.95 | 0.046 |
CASC5 | cancer susceptibility candidate 5 | 1.93 | 0.029 |
ESCO2 | establishment of cohesion 1 homolog 2 | 1.93 | 0.032 |
HIST2H2BF | histone cluster 2, H2bf | 1.91 | 0.039 |
HELLS | helicase, lymphoid-specific | 1.90 | 0.013 |